Deletion of Hang Yin

Comment: Satisfies 
Stance: keep
Cited policy: Wikipedia:Notability (WP:PROF)

Comment: I restored this article as it had been PRODed without discussion. While I agree that the article subject's citation record is impressive, this does not establish notability. Criterion 1 of , I would argue, requires more than a list. Of the sources referenced in the article, the majority are not independent of the subject. Those that are independent are little more than trivial coverage. Of course, being named in a Nature news piece is impressive, but it does not establish notability. My main concern with this article is one of . The article has clearly been placed on Wikipedia as a promotional piece by either the subject or people close to him. These people are the same s that are arguing to keep above
Stance: delete
Cited policy: Wikipedia:Notability (WP:PROF||WP:SPIP||WP:SPA)

Comment: If kept, it would be primarily because of the awards. However, I looked at some of the award sites and many of these are grants that are given to a large number of researchers -- eg the NSF career grant is given to 100-150 researchers per year. What bothers me, though, is that this appears to be primarily a self-promotion, and it has carried through to this AfD. The author of the article has added and deleted !votes here a number of times, which is contrary to the culture of transparency that should govern this area, IMO. With such an undisclosed  it would be necessary to keep a close eye on this article to avoid wp:promo. However, I don't think that the article is worth that effort
Stance: delete
Cited policy: Wikipedia:Conflict of interest (WP:COI)

Comment: He's an associate professor, not yet at the level where notability is typical, and none of the junior-researcher awards listed contributes much for notability. But I think his citation record https://scholar.google.com/citations?user=UizQeO4AAAAJ is good enough for #C1
Stance: keep
Cited policy: Wikipedia:Notability (WP:PROF)

Comment: Positive social impact has been made through investigational drugs {{cite web|title=Market Watch |url=http://www.marketwatch.com/story/biolinerx-in-licenses-novel-compound-for-treatment-of-neuropathic-pain-2014-06-23}} Improvement and updates have been implemented to the page, which should have established . —&nbsp; comment added by
Stance: keep
Cited policy: Wikipedia:Notability (WP:PROF)